Provided by Tiger Trade Technology Pte. Ltd.

EyePoint

5.32
-0.0800-1.48%
Post-market: 5.30-0.0200-0.38%19:57 EDT
Volume:8.19M
Turnover:42.51M
Market Cap:458.65M
PE:-1.41
High:5.50
Open:5.48
Low:4.98
Close:5.40
52wk High:19.11
52wk Low:3.95
Shares:86.21M
Float Shares:64.06M
Volume Ratio:0.47
T/O Rate:12.78%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7642
EPS(LYR):-3.1667
ROE:-148.70%
ROA:-74.85%
PB:2.76
PE(LYR):-1.68

Loading ...

RBC Capital Adjusts EyePoint Pharmaceuticals PT to $37 From $39, Maintains Outperform Speculative-Risk Rating

MT Newswires Live
·
May 07

EyePoint Pharmaceuticals (EYPT) Gets a Buy from Guggenheim

TIPRANKS
·
May 07

EyePoint reports Q1 EPS (99c), consensus (81c)

TIPRANKS
·
May 07

Analysts Are Bullish on These Healthcare Stocks: EyePoint Pharmaceuticals (EYPT), BeOne Medicines (ONC)

TIPRANKS
·
May 07

Analysts Offer Insights on Healthcare Companies: EyePoint Pharmaceuticals (EYPT) and 908 Devices (MASS)

TIPRANKS
·
May 07

EyePoint Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 06

Earnings Flash (EYPT) EyePoint Posts Q1 Loss $0.99 a Share, vs. FactSet Est of $0.79 Loss

MT Newswires Live
·
May 06

EyePoint Pharmaceuticals Q1 net loss widens on increased R&D spending

Reuters
·
May 06

EyePoint Q1 FY26 net loss widens to $84.8 million; revenue drops to $0.7 million

Reuters
·
May 06

EyePoint Pharmaceuticals Q1 EPS $(0.99) Misses $(0.80) Estimate, Sales $696.000K Beat $352.833K Estimate

Benzinga Earnings
·
May 06

EyePoint Pharmaceuticals Q1 Basic EPS USD -0.99

THOMSON REUTERS
·
May 06

EyePoint Inc - Cash Position Expected to Fund Operations Into Q4 2027

THOMSON REUTERS
·
May 06

EyePoint Pharmaceuticals Q1 Net Income USD -84.832 Million

THOMSON REUTERS
·
May 06

EyePoint Pharmaceuticals Q1 Product Sales USD 467 Thousand

THOMSON REUTERS
·
May 06

EyePoint Pharmaceuticals Q1 Operating Expenses USD 87.922 Million

THOMSON REUTERS
·
May 06

EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments

GlobeNewswire
·
May 06

EyePoint schedules first-quarter results conference call and webcast

Reuters
·
Apr 29

EyePoint to Report First Quarter 2026 Financial Results on May 6, 2026

GlobeNewswire
·
Apr 29

Insiders Dump Shares in Global-e, EyePoint, Immunovant, Nerdy, Argan

TIPRANKS
·
Apr 25

Top Executive Makes Strategic Move With EyePoint Pharmaceuticals Stock

TIPRANKS
·
Apr 21